Evidence map›Paper›PMID 28837667›Full record

ArticlePLoS pathogens2017

Influenza NS1 directly modulates Hedgehog signaling during infection.

Margery G Smelkinson, Annabel Guichard, John R Teijaro, Meghana Malur, Maria Eugenia Loureiro, Prashant Jain, Sundar Ganesan, Elina I Zúñiga, Robert M Krug, Michael B Oldstone and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. IntegratingFrontiers in pharmacology · 2025
    Article
  3. Cell signaling inFrontiers in cellular and infection microbiology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Repurposing Antifungals for Host-Directed Antiviral Therapy?Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  10. Review
  11. Hedgehog Signaling: Implications in Cancers and Viral Infections.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Margery G SmelkinsonSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, California, United States of America.ORCID http://orcid.org/0000-0001-7777-5574
Annabel GuichardSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, California, United States of America.ORCID http://orcid.org/0000-0003-1251-1193
John R TeijaroImmunology and Microbial Science, Scripps Research Institute, La Jolla, California, United States of America.
Meghana MalurDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.ORCID http://orcid.org/0000-0002-2181-3006
Maria Eugenia LoureiroDivision of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.ORCID http://orcid.org/0000-0001-7965-0177
Prashant JainSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, California, United States of America.ORCID http://orcid.org/0000-0001-7179-9874
Sundar GanesanBiological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Elina I ZúñigaDivision of Biological Sciences, University of California San Diego, La Jolla, California, United States of America.
Robert M KrugDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
Michael B OldstoneImmunology and Microbial Science, Scripps Research Institute, La Jolla, California, United States of America.ORCID http://orcid.org/0000-0003-0804-0501
Ethan BierSection of Cell and Developmental Biology, University of California, San Diego, La Jolla, California, United States of America.ORCID http://orcid.org/0000-0002-2892-3005
University of California San Diego · USScripps Research Institute · USThe University of Texas at Austin · USConsejo Nacional de Investigaciones Científicas y Técnicas · ARNational Institutes of Health · US

Funding

REPLICATION OF INFLUENZA VIRUSR01AI011772 · NIAID · UNIVERSITY OF TEXAS AUSTIN · PI KRUG, ROBERT M · 1985 to 2017
$10.7M
Novel Chemical and Immunological Approaches to Influenza TherapyU01AI074564 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI OLDSTONE, MICHAEL B · 2007 to 2011
$8.1M
Inhibitory Pathways Underlying Viral Persistence In VivoR01AI081923 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Elina I Zuniga · 2009 to 2026
$6.6M
MOLECULAR BASIS OF VIRAL PATHOGENESIST32AI007354 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI DE LA TORRE, JUAN C. · 1989 to 2020
$5.2M
Positive Immune-regulators During Chronic Viral InfectionsR01AI113923 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZUNIGA, ELINA I · 2015 to 2024
$5.1M
Analyzing a novel mechanism of action of bacterial cAMP producing toxinsR01AI110713 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN, NIZET, VICTOR · 2014 to 2018
$2.7M
Analyzing Anthrox Toxins in DrosophilaR01AI070654 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN · 2008 to 2012
$1.9M
Analyzing Anthrax Toxins in DrosophiliaR56AI070654 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BIER, ETHAN · 2013 to 2013
$364k
Influenza NS1: analysis of cellular targets and generation of peptide inhibitorsF32AI078672 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMELKINSON, MARGERY GAIL · 2009 to 2010
$102k
NIAID NIH HHS F32 AI078672NIAID NIH HHS R01 AI011772NIAID NIH HHS R01 AI070654NIAID NIH HHS R01 AI081923NIAID NIH HHS R01 AI110713NIAID NIH HHS R01 AI113923NIAID NIH HHS R56 AI070654NIAID NIH HHS T32 AI007354NIAID NIH HHS U01 AI074564
6 · The paper itself

Abstract

The multifunctional NS1 protein of influenza A viruses suppresses host cellular defense mechanisms and subverts other cellular functions. We report here on a new role for NS1 in modifying cell-cell signaling via the Hedgehog (Hh) pathway. Genetic epistasis experiments and FRET-FLIM assays in Drosophila suggest that NS1 interacts directly with the transcriptional mediator, Ci/Gli1. We further confirmed that Hh target genes are activated cell-autonomously in transfected human lung epithelial cells expressing NS1, and in infected mouse lungs. We identified a point mutation in NS1, A122V, that modulates this activity in a context-dependent fashion. When the A122V mutation was incorporated into a mouse-adapted influenza A virus, it cell-autonomously enhanced expression of some Hh targets in the mouse lung, including IL6, and hastened lethality. These results indicate that, in addition to its multiple intracellular functions, NS1 also modifies a highly conserved signaling pathway, at least in part via cell autonomous activities. We discuss how this new Hh modulating function of NS1 may influence host lethality, possibly through controlling cytokine production, and how these new insights provide potential strategies for combating infection.

Indexed as

AnimalsDrosophilaHedgehog ProteinsHumansImmunohistochemistryInfluenza A Virus, H5N1 SubtypeMiceMice, Inbred C57BLOrthomyxoviridae InfectionsSignal TransductionViral Nonstructural ProteinsHedgehog ProteinsINS1 protein, influenza virusViral Nonstructural Proteins

Identifiers

PMID28837667
PMCPMC5587344
OpenAlexW2745486217

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.